Arun Jesudian, MD

Hepatology experts discuss educating patients with hepatic encephalopathy on managing medications and supplements.

Kimberly A. Brown, MD, shares approaches to educating patients on management of hepatic encephalopathy and the importance of medication adherence and nutrition.

Expert hepatologists comment on primary care providers using rifaximin to manage and prevent episodes of hepatic encephalopathy.

Arun B. Jesudian, MD, and Kimberly A. Brown, MD, highlight clinical trial data of rifaximin for the treatment of hepatic encephalopathy.

James Williams, MS, DO, FACEP, provides insight on the importance of medication reconciliation when managing patients with hepatic encephalopathy.

Arun Jesudian, MD, and James Williams, MS, DO, FACEP, highlight precipitating factors for HE and medication compliance for the condition.

Kimberly A. Brown, MD, reviews the use of lactulose and rifaximin as first-line treatment of hepatic encephalopathy.

Arun B. Jesudian, MD, and Kimberly A. Brown, MD, discuss conditions that may be mistaken for hepatic encephalopathy.

An expert in emergency medicine and a transplant hepatologist consider common infections that patients with hepatic encephalopathy should be evaluated for.

Drs Arun Jesudian and James Williams discuss treatment with lactulose and rifaximin for patients with hepatic encephalopathy and clinical data on their effect on hospital length of stay.

Experts in hepatology comment on effectiveness of diagnostic testing hepatic encephalopathy.

Expert hepatologists discuss how to identify patients with hepatic encephalopathy who require hospitalization vs outpatient care.

James Williams, MS, DO, FACEP, comments on current treatment options and treatment selection for hepatic encephalopathy.

Arun Jesudian, MD, and James Williams, MS, DO, FACEP, review the AASLD and EASL guideline approaches to the management of overt hepatic encephalopathy (HE) and comment on the grading of HE based on presentation.

Kimberly A. Brown, MD, comments on the life-threatening nature of recurrent HE and how to navigate patient conversations.

Experts in hepatology discuss the pathophysiology of HE and how certain factors influence the brain in HE.

Dr James Williams shares insight on factors leading to delays in hepatic encephalopathy (HE) diagnosis, the importance of early detection, and strategies to improve diagnosis in the in-patient setting.

An expert in emergency medicine outlines his approach to the clinical evaluation of hepatic encephalopathy.

Kimberly A. Brown, MD, reviews classifying the severity of HE and defines covert vs overt HE.

Arun B. Jesudian, MD, and Kimberly A. Brown, MD, provide an overview of hepatic encephalopathy, signs and symptoms, and underlying liver disease as a major risk factor.

Drs Arun Jesudian and James Williams share thoughts on patients with hepatic encephalopathy who are at risk of hospitalization, poorer patient and economic outcomes associated with readmission rates, and the impact of hepatic encephalopathy on quality of life.

James Williams, MS, DO, FACEP, describes the presentation of hepatic encephalopathy (HE) in patients and challenges associated with diagnosis.